Trurevmed Consultancy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-12-2024
- Paid Up Capital ₹ 0.10 M
as on 27-12-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 69.42%
(FY 2023)
- Profit 287.78%
(FY 2023)
- Ebitda 366.31%
(FY 2023)
- Net Worth 47.68%
(FY 2023)
- Total Assets 224.60%
(FY 2023)
About Trurevmed Consultancy
The Corporate was formerly known as Trurev Med Consultancy Private Limited. The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anton Pillai, Prabin Padmanabhan, and Dheepa Samuel serve as directors at the Company.
- CIN/LLPIN
U72900TN2017PTC117207
- Company No.
117207
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Trurevmed Consultancy?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anton Pillai  | Managing Director | 13-Aug-2018 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prabin Padmanabhan | Director | 22-Jun-2017 | Current |
| Dheepa Samuel | Director | 14-Feb-2024 | Current |
Financial Performance of Trurevmed Consultancy.
Trurevmed Consultancy Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 69.42% increase. The company also saw a substantial improvement in profitability, with a 287.78% increase in profit. The company's net worth Soared by an impressive increase of 47.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trurevmed Consultancy?
Unlock access to Trurevmed Consultancy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trurevmed Consultancy?
Unlock and access historical data on people associated with Trurevmed Consultancy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trurevmed Consultancy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trurevmed Consultancy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
